0001209191-18-003981.txt : 20180117 0001209191-18-003981.hdr.sgml : 20180117 20180117164530 ACCESSION NUMBER: 0001209191-18-003981 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180116 FILED AS OF DATE: 20180117 DATE AS OF CHANGE: 20180117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIDEN JEFFREY M CENTRAL INDEX KEY: 0001242825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18531895 MAIL ADDRESS: STREET 1: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-16 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001242825 LEIDEN JEFFREY M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 1 0 0 CEO & President Common Stock 2018-01-16 4 M 0 44250 48.74 A 176747 D Common Stock 2018-01-16 4 M 0 55313 45.11 A 232060 D Common Stock 2018-01-16 4 S 0 42371 155.77 D 189689 D Common Stock 2018-01-16 4 S 0 19808 156.62 D 169881 D Common Stock 2018-01-16 4 S 0 11471 157.67 D 158410 D Common Stock 2018-01-16 4 S 0 17918 158.79 D 140492 D Common Stock 2018-01-16 4 S 0 7995 159.39 D 132497 D Common Stock 440 I 401(k) Stock Option (Right to Buy) 48.74 2018-01-16 4 M 0 44250 0.00 D 2022-07-24 Common Stock 44250 0 D Stock Option (Right to Buy) 45.11 2018-01-16 4 M 0 55313 0.00 D 2023-02-04 Common Stock 55313 0 D Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $155.77 (range $155.18 to $156.17). Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $156.62 (range $156.18 to $157.17). Open market sales reported on this line occurred at a weighted average price of $157.67 (range $157.18 to $158.17). Open market sales reported on this line occurred at a weighted average price of $158.79 (range $158.18 to $159.16). Open market sales reported on this line occurred at a weighted average price of $159.39 (range $159.18 to $159.75). Fully vested. /s/ Omar White, Attorney-in-Fact 2018-01-17